Analysts Viewpoint
Revance Therapeutics Inc [RVNC] Records 50-Day SMA of $4.89
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Menu
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Revance Therapeutics Inc’s recently made public that its Chief Commercial Officer Jordan Erica unloaded Company’s shares for reported $9096.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Revance Therapeutics
Revance Therapeutics Inc’s recently made public that its Chief Commercial Officer Jordan Erica unloaded Company’s shares for reported $9096.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Revance Therapeutics Inc’s recent filing unveils that its CFO Schilke Tobin unloaded Company’s shares for reported $47204.0 on Mar 18
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Revance Therapeutics
Revance Therapeutics Inc’s recently made public that its CFO Schilke Tobin unloaded Company’s shares for reported $47204.0 on Mar 18